To determine if giving live Sendai virus (in the form of a vaccine) to children through their nose is safe (causes no serious illness) 6 months after enrollment complete [clinicaltrials_resource:58c269aff52bf8fdc2c50cee6552ce80]
Participants will be studied in three cohorts:
Healthy seropositive children 3 years up to 6 years
Healthy seropositive toddlers 12 months up to 24 months
Healthy seronegative toddlers 12 months up to 24 months.
Each cohort will receive Sendai virus vaccine.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To determine if giving live Sendai virus (in the form of a vaccine) to children through their nose is safe (causes no serious illness) 6 months after enrollment complete [clinicaltrials_resource:58c269aff52bf8fdc2c50cee6552ce80]
Participants will be studied in three cohorts:
Healthy seropositive children 3 years up to 6 years
Healthy seropositive toddlers 12 months up to 24 months
Healthy seronegative toddlers 12 months up to 24 months.
Each cohort will receive Sendai virus vaccine.
Bio2RDF identifier
58c269aff52bf8fdc2c50cee6552ce80
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:58c269aff52bf8fdc2c50cee6552ce80
measure [clinicaltrials_vocabulary:measure]
To determine if giving live Se ...... fe (causes no serious illness)
time frame [clinicaltrials_vocabulary:time-frame]
6 months after enrollment complete
description
Participants will be studied i ...... receive Sendai virus vaccine.
identifier
clinicaltrials_resource:58c269aff52bf8fdc2c50cee6552ce80
title
To determine if giving live Se ...... nths after enrollment complete
@en
type
label
To determine if giving live Se ...... 269aff52bf8fdc2c50cee6552ce80]
@en